Zhejiang Conba Pharmaceutical Co., Ltd. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Conba Pharmaceutical Co., Ltd. with three other
companies in this sector in China:
Dong-E-E-Jiao Co Ltd
sales of 6.32 billion Chinese Renmimbi [US$997.16 million]
of which 89%
was Medicine Manufacturing),
Zhejiang Medicine Co., Ltd.
(5.28 billion Chinese Renmimbi [US$833.26 million]
of which 44%
was Life Nourishment), and
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited
(6.18 billion Chinese Renmimbi [US$975.33 million]
of which 66%
was Chinese Medicine).
Zhejiang Conba Pharmaceutical Co., Ltd. reported sales of 6.02 billion Chinese Renmimbi (US$950.16 million)
December of 2016.
increase of 13.6%
versus 2015, when the company's sales were 5.30 billion Chinese Renmimbi.
Sales at Zhejiang Conba Pharmaceutical Co., Ltd. have increased during each of the previous five years
(and since 2011, sales have increased a total of 184%).
Sales of Commerce saw an increase
that was more than double the company's growth rate: sales were up
36.2% in 2016, from
1.54 billion Chinese Renmimbi to 2.10 billion Chinese Renmimbi.
Not all segments of Zhejiang Conba Pharmaceutical Co., Ltd. experienced an increase in sales in 2016:
sales of Value Added Service fell 8.1% to 22.02 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).
Zhejiang Conba Pharmaceutical Co., Ltd. also experienced decreases in sales in
Other (down 0.9% to 14.85 million Chinese Renmimbi)